3-Heterocyclyl-indole inhibitors of glycogen synthase kinase-3

US7399780B2 · kind B2 · utility

Assignee

• ASTRAZENECA AB · SE

Inventors

• Stefan Berg · Ekerö, SE
• Sven Hellberg · Malung, SE
• Martin Nylof · Malung, SE
• Yafeng Xue · Timrå, SE

Key dates

• Filing date: Mar 28, 2003
• Grant date: Jul 15, 2008
• Expiry date: May 18, 2024

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention provides new compounds of formula Ia and Ib: as well as a process for their preparation and new intermediates used therein, pharmaceutical formulations containing said therapeutically active compounds and to the use of said active compounds in therapy.